B. Cao

发表

Negative auto-regulators trap p53 in their web.

Xiaoping Zhou, B. Cao, Hua Lu, 2017, Journal of molecular cell biology.

20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer

Xueqi Fu, B. Cao, W. Guo, 2014, PloS one.

Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration‐resistant prostate cancer

B. Cao, Hua Lu, Qi Zhang, 2013, International journal of cancer.

RNA-binding Motif Protein 10 Induces Apoptosis and Suppresses Proliferation by Activating p53

B. Cao, Hua Lu, Hyemin Lee, 2019, Oncogene.

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy

Zhiyong Guo, Y. Dong, S. Plymate, 2014, Oncotarget.

Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes.

S. Gambhir, B. Cao, O. Sartor, 2015, Cancer research.

Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

Oliver Sartor, Jing Li, Bo Cao, 2011, Molecular Cancer Therapeutics.

Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.

G. Del Sal, B. Cao, Hua Lu, 2017, Molecular cell.

20(S)‐protopanaxadiol‐aglycone downregulation of the full‐length and splice variants of androgen receptor

Xueqi Fu, P. Rennie, B. Cao, 2013, International journal of cancer.

Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator

Xiaoping Zhou, B. Cao, Hua Lu, 2016, eLife.

New insights into p53 functions through its target microRNAs.

Xiaoping Zhou, B. Cao, Hua Lu, 2014, Journal of molecular cell biology.

SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer

B. Cao, Hua Lu, J. Liao, 2018, eLife.

SPIN1 promotes tumorigenesis by blocking the uL18-MDM2-p53 pathway

B. Cao, Hua Lu, J. Liao, 2017, bioRxiv.

Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition

H. Lu, B. Cao, J. Liao, 2014, Cell Death and Differentiation.

Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit

Xiaoping Zhou, B. Cao, Hua Lu, 2017, Oncotarget.

Inauhzin(c) Inactivates c-Myc Independently of p53

Xiaoping Zhou, B. Cao, Hua Lu, 2015, Cancer biology & therapy.

Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53

Xiaoping Zhou, B. Cao, Hua Lu, 2016, Nature Communications.

TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene

B. Cao, Hua Lu, J. Liao, 2016, Scientific Reports.

Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation

Xiaoping Zhou, B. Cao, Hua Lu, 2016, eLife.

Crotonylation at serine 46 impairs p53 activity.

W. Wimley, B. Cao, Hua Lu, 2020, Biochemical and biophysical research communications.

Cancer-derived C-terminus-extended p53 mutation confers dominant-negative effect on its wild-type counterpart

B. Cao, Hua Lu, O. Sartor, 2021, Journal of molecular cell biology.

Disruption of the Putative Ribosome-Binding Motif of a Scaffold Protein Impairs Cytochrome c Oxidase Subunit Expression in Leishmania major

B. Cao, Hua Lu, B. Kelly, 2019, mSphere.